Helen Torley

Helen Torley, President And CEO at Halozyme Therapeutics (NASDAQ:HALO), made a large buy and sell of company shares on November 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Helen Torley exercised options to purchase 50...

Helen Torley, President And CEO at Halozyme Therapeutics (NASDAQ:HALO), made a large buy and sell of company shares on October 4, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Helen Torley exercised options to purchase 50,...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has developed a new drug called PEGPH 20, which is changing the way pancreatic cancer patients are treated. Helen Torley, Halozyme Therapeutics CEO, was on CNBC Monday to shed more light on the drug and the success it has had. PEGPH 20 "Some...